Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - Nasdaq - US12448X2018 - Common Stock - Currency: USD

33.18  +1.55 (+4.9%)

After market: 33.5 +0.32 (+0.96%)

Fundamental Rating

6

BYRN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 66 industry peers in the Aerospace & Defense industry. BYRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BYRN shows excellent growth, but is valued quite expensive already. These ratings would make BYRN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
BYRN had a positive operating cash flow in the past year.
In the past 5 years BYRN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: BYRN reported negative operating cash flow in multiple years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

BYRN's Return On Assets of 20.33% is amongst the best of the industry. BYRN outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 25.41%, BYRN belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.46%, BYRN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA 20.33%
ROE 25.41%
ROIC 11.46%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

With an excellent Profit Margin value of 15.15%, BYRN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
With a Operating Margin value of 8.95%, BYRN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
The Gross Margin of BYRN (61.97%) is better than 96.92% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

8

2. Health

2.1 Basic Checks

BYRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BYRN has more shares outstanding
The number of shares outstanding for BYRN has been increased compared to 5 years ago.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 33.03. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 33.03, BYRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 33.03
ROIC/WACC1.14
WACC10.06%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

BYRN has a Current Ratio of 3.99. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
BYRN has a Current ratio of 3.99. This is amongst the best in the industry. BYRN outperforms 81.54% of its industry peers.
BYRN has a Quick Ratio of 2.09. This indicates that BYRN is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.09, BYRN is doing good in the industry, outperforming 67.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 2.09
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1700.00% over the past year.
Looking at the last year, BYRN shows a very strong growth in Revenue. The Revenue has grown by 87.24%.
The Revenue has been growing by 147.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%

3.2 Future

BYRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.26% yearly.
The Revenue is expected to grow by 18.79% on average over the next years. This is quite good.
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue Next Year34.98%
Revenue Next 2Y28.09%
Revenue Next 3Y30.28%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 51.84 indicates a quite expensive valuation of BYRN.
BYRN's Price/Earnings ratio is in line with the industry average.
BYRN is valuated expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
BYRN is valuated quite expensively with a Price/Forward Earnings ratio of 43.09.
The rest of the industry has a similar Price/Forward Earnings ratio as BYRN.
BYRN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 51.84
Fwd PE 43.09
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BYRN is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 71.29
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of BYRN may justify a higher PE ratio.
A more expensive valuation may be justified as BYRN's earnings are expected to grow with 12.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.45%
EPS Next 3Y12.26%

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (7/3/2025, 7:06:33 PM)

After market: 33.5 +0.32 (+0.96%)

33.18

+1.55 (+4.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-10 2025-04-10/bmo
Earnings (Next)07-10 2025-07-10/bmo
Inst Owners59.39%
Inst Owner Change14.15%
Ins Owners19.33%
Ins Owner Change1.09%
Market Cap752.19M
Analysts84
Price Target36.59 (10.28%)
Short Float %20.2%
Short Ratio8.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)175.38%
Min EPS beat(2)96.08%
Max EPS beat(2)254.68%
EPS beat(4)4
Avg EPS beat(4)157.7%
Min EPS beat(4)47.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-2.94%
EPS beat(12)7
Avg EPS beat(12)-16.34%
EPS beat(16)9
Avg EPS beat(16)13.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-2.03%
Max Revenue beat(2)1.52%
Revenue beat(4)2
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)5.2%
Revenue beat(8)4
Avg Revenue beat(8)3.84%
Revenue beat(12)4
Avg Revenue beat(12)-1.38%
Revenue beat(16)6
Avg Revenue beat(16)1.81%
PT rev (1m)0.7%
PT rev (3m)0.7%
EPS NQ rev (1m)13.56%
EPS NQ rev (3m)24.62%
EPS NY rev (1m)1.45%
EPS NY rev (3m)-7.28%
Revenue NQ rev (1m)6.61%
Revenue NQ rev (3m)9.66%
Revenue NY rev (1m)2.51%
Revenue NY rev (3m)5.64%
Valuation
Industry RankSector Rank
PE 51.84
Fwd PE 43.09
P/S 7.89
P/FCF N/A
P/OCF 187.02
P/B 13.24
P/tB 14.66
EV/EBITDA 71.29
EPS(TTM)0.64
EY1.93%
EPS(NY)0.77
Fwd EY2.32%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.18
OCFY0.53%
SpS4.2
BVpS2.51
TBVpS2.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 20.33%
ROE 25.41%
ROCE 14.5%
ROIC 11.46%
ROICexc 17.05%
ROICexgc 19.82%
OM 8.95%
PM (TTM) 15.15%
GM 61.97%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 302.89%
Cap/Sales 5.06%
Interest Coverage 250
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 3.99
Quick Ratio 2.09
Altman-Z 33.03
F-Score7
WACC10.06%
ROIC/WACC1.14
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1700%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue 1Y (TTM)87.24%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%57.26%
Revenue Next Year34.98%
Revenue Next 2Y28.09%
Revenue Next 3Y30.28%
Revenue Next 5Y18.79%
EBIT growth 1Y243.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year234.99%
EBIT Next 3Y81.16%
EBIT Next 5Y53.44%
FCF growth 1Y92.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y145.86%
OCF growth 3YN/A
OCF growth 5YN/A